RecruitingPhase 3NCT06878261
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Sponsor: AstraZeneca
Evanston, IL · Hinsdale, IL · Springfield, IL · +77 more sites
Clinical trials in Hinsdale, IL
13 recruiting studies have a site in or near Hinsdale, IL, Illinois.
Top conditions here
All conditions
- Alzheimer's Disease
- Asthma
- Breast Cancer
- COPD
- Crohn's Disease
- Depression
- Type 1 Diabetes
- Type 2 Diabetes
- Heart Failure
- Hypertension
- Leukemia
- Lung Cancer
- Lupus
- Migraine
- Multiple Sclerosis
- Obesity
- Parkinson's Disease
- Prostate Cancer
- Psoriasis
- Rheumatoid Arthritis
- Schizophrenia
- Sickle Cell Disease
- Ulcerative Colitis
- Colorectal Cancer
Showing 13 of 13 studies
RecruitingPhase 2NCT07476287
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
Sponsor: Pfizer
Hinsdale, IL · New Lenox, IL · +21 more sites
RecruitingPhase 3NCT07222566
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Sponsor: Pfizer
Arlington Heights, IL · Bloomington, IL · Chicago, IL · +223 more sites
RecruitingPhase 3NCT07222800
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Sponsor: Pfizer
Arlington Heights, IL · Bloomington, IL · Chicago, IL · +251 more sites
RecruitingNot applicableNCT07069738
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
Sponsor: Boston Scientific Corporation
Hinsdale, IL · Naperville, IL · +40 more sites
RecruitingPhase 3NCT06357533
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Sponsor: AstraZeneca
Hinsdale, IL · +62 more sites
RecruitingPhase 3NCT06252649
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
Sponsor: Amgen
Chicago, IL · Hinsdale, IL · Skokie, IL · +23 more sites
RecruitingPhase 3NCT06801834
Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
Sponsor: Gilead Sciences
Hinsdale, IL · Springfield, IL · +20 more sites
RecruitingPhase 1 / Phase 2NCT04657068
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Sponsor: Artios Pharma Ltd
Hinsdale, IL · +40 more sites
RecruitingPhase 2NCT06937177
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
Sponsor: Endevica Bio
Chicago, IL · Hinsdale, IL · Skokie, IL · +22 more sites
RecruitingPhase 4NCT05390892
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
Sponsor: Brigham and Women's Hospital
Chicago, IL · Hinsdale, IL · +34 more sites
RecruitingPhase not listedNCT05236114
GEMINI-NSCLC: NSCLC Biomarker Study
Sponsor: Tempus AI
Carterville, IL · Decatur, IL · Evanston, IL · +55 more sites
RecruitingPhase 3NCT05929768
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Sponsor: SWOG Cancer Research Network
Alton, IL · Aurora, IL · +952 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.